OneChain Immunotherapeutics
Barcelona
About OneChain Immunotherapeutics
OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.9M
- Funding stage: Seed
- Last round: Seed (Jun 2023)
- Website: onechaintx.com
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/onechain-immunotherapeutics-88933 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.